Literature DB >> 20943322

Efficacy of a moxidectin/triclabendazole oral formulation against mixed infections of Fasciola hepatica and gastrointestinal nematodes in sheep.

M Martínez-Valladares1, C Cordero-Pérez, L Castañón-Ordóñez, M R Famularo, N Fernández-Pato, F A Rojo-Vázquez.   

Abstract

We have evaluated the efficacy in sheep of a combination drench formulation at the recommended dose rate of 0.2 mg moxidectin/kg bodyweight and 10 mg triclabendazole/kg bodyweight against an experimental infection with Fasciola hepatica and a natural infection with gastrointestinal nematodes. We confirmed that the efficacy of reducing fecal egg output was 98.3% for trichostrongyle eggs and 100% for F. hepatica eggs. Based on adult worm and fluke recovery, the efficacy varied according to the target species. A reduction was found in the number of Teladorsagia circumcincta, Trichostrongylus spp., Nematodirus spp., and Trichuris spp. greater than 95%, but the efficacy for Oesophagostomum spp. varied, with values below 90%. The reduction in F. hepatica was higher than 95% for all stages. The effectiveness of the formulation was also confirmed by an increase in total proteins and albumin following treatment.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943322     DOI: 10.1016/j.vetpar.2010.07.008

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  Intraspecific mitochondrial DNA variation of Fasciola hepatica eggs from sheep with different level of anthelmintic resistance.

Authors:  María Martínez-Valladares; Francisco A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2014-05-16       Impact factor: 2.289

2.  Characterization of a multidrug resistant Teladorsagia circumcincta isolate from Spain.

Authors:  M Martínez-Valladares; M R Famularo; N Fernández-Pato; C Cordero-Pérez; L Castañón-Ordóñez; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2011-12-17       Impact factor: 2.289

3.  Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.

Authors:  J M Martínez-Pérez; D Robles-Pérez; F Valcárcel-Sancho; A M González-Guirado; I Casanova-García de Castro; J M Nieto-Martínez; F A Rojo-Vázquez; M Martínez-Valladares
Journal:  Parasitol Res       Date:  2013-06-06       Impact factor: 2.289

4.  Comparative assessment of recombinant and native immunogenic forms of Fasciola hepatica proteins for serodiagnosis of sheep fasciolosis.

Authors:  Kobra Mokhtarian; Ahmad Reza Meamar; Majid Khoshmirsafa; Elham Razmjou; Leila Masoori; Majid Khanmohammadi; Lame Akhlaghi; Reza Falak
Journal:  Parasitol Res       Date:  2017-12-04       Impact factor: 2.289

Review 5.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

6.  Prevalence of gastrointestinal nematodes and Fasciola hepatica in sheep in the northwest of Spain: relation to climatic conditions and/or man-made environmental modifications.

Authors:  María Martínez-Valladares; David Robles-Pérez; José Manuel Martínez-Pérez; Coral Cordero-Pérez; María Del Rosario Famularo; Nélida Fernández-Pato; Camino González-Lanza; Luciano Castañón-Ordóñez; Francisco A Rojo-Vázquez
Journal:  Parasit Vectors       Date:  2013-09-27       Impact factor: 3.876

7.  Loop-mediated isothermal amplification (LAMP) assay for the diagnosis of fasciolosis in sheep and its application under field conditions.

Authors:  María Martínez-Valladares; Francisco Antonio Rojo-Vázquez
Journal:  Parasit Vectors       Date:  2016-02-05       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.